NSNina Lisbeth Shapiro

Nina Lisbeth Shapiro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nina Lisbeth Shapiro has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Neil Bhattacharyya

    Department of Otology, Rhinology, and Laryngology, Harvard Medical School, Boston, Massachusetts, USA

    8 shared publications
  • Ali M. Strocker

    2 shared publications
  • Donald B. Kearns

    Pediatric Otolaryngology Institute, Children’s Hospital of San Diego, 3030 Children’s Way, Suite 402, San Diego, CA 92123, USA

    2 shared publications
  • Allan B. Seid

    Pediatric Otolaryngology Institute, Children’s Hospital of San Diego, 3030 Children’s Way, Suite 402, San Diego, CA 92123, USA

    1 shared publication
  • Anthony E. Magit

    Pediatric Otolaryngology Institute, Children’s Hospital of San Diego, 3030 Children’s Way, Suite 402, San Diego, CA 92123, USA

    1 shared publication
  • Ayal Willner

    701 East 28th Street, Suite 412, Long Beach, CA 90806, USA

    1 shared publication

Latest Publications

  • Tongue Tie in Infancy

    by Sophie Shay, Rachel Mandelbaum, Nina Shapiro

  • Epstein‐barr DNA serology and positron‐emission tomography imaging of the head and neck in pediatric transplant recipients

    by Douglas Sidell, Robert S. Venick, Nina L. Shapiro

    Objectives/Hypothesis: Epstein‐Barr virus (EBV) infection is a potential precursor of post‐transplantation lymphoproliferative disorder (PTLD) in the pediatric transplant patient. Positron‐emission tomography (PET) imaging is increasingly utilized in this population to monitor for neoplasia and PTLD. We assess the association between EBV serum titers and Waldeyer's ring and cervical lymph node PET positivity in the pediatric transplant recipient.Study Design: Retrospective analysis of EBV serology and PET imaging results in pediatric orthotopic liver transplantation (OLT) recipients.Methods: Imaging results and laboratory data were reviewed for all pediatric OLT recipients from January 2005 to July 2011 at a single institution. Charts were evaluated for PET positivity at Waldeyer's ring or cervical lymphatics, and for EBV serology results. Demographic data extracted include patient sex and age at transplantation.Results: A total of 122 pediatric OLT recipients were reviewed. Twelve patients (10%) underwent PET imaging. Overall, four patients (33%) had evidence of PET positivity at Waldeyer's ring or cervical lymphatics. Five patients (42%) had positive EBV serology. There was a significant association between PET imaging results and EBV DNA serology results (P = .01).Conclusions: PTLD surveillance in the pediatric transplant recipient is an important component of long‐term care in this population. Although PET imaging is a new modality in monitoring pediatric transplant recipients for early signs of PTLD, an association between EBV serology and PET imaging results appears to exist. With increased implementation, PET imaging will likely prove valuable in its ability to monitor the transplant recipient at risk for PTLD.Level of Evidence: 4 Laryngoscope, 124:1236–1241, 2014


  • Open Access

    Laryngomalacia Presenting as Recurrent Croup in an Infant

    by Osama Elbuluk, Travis Shiba, Nina L. Shapiro

    Laryngomalacia is a common disease of infancy which can present with atypical symptoms and at an atypical age, causing the diagnosis to often be overlooked. We report a case of a male patient who was diagnosed with laryngomalacia at the age of three months. The patient’s inspiratory stridor resolved within a year, but he went on to develop atypical croup. The patient was later diagnosed with severe laryngomalacia which complicated his “croup-like” symptoms. He subsequently underwent supraglottoplasty with complete resolution of symptoms.


  • Association between epstein‐barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients

    by Nina L. Shapiro, Christopher Guan‐Zhong Tang, Neil Bhattacharyya

    Objectives/Hypothesis: Assess whether changes in Epstein‐Barr virus (EBV) serology status relates to immunohistochemical evidence of active EBV infection in tonsillar tissue of pediatric organ transplant recipients. Children who seroconvert from EBV seronegative to seropositive status following organ transplantation are more likely to develop evidence of active EBV tonsillar infection than those who do not seroconvert. Active EBV infection is a potential early precursor of post‐transplantation lymphoproliferative disorder (PTLD), a life‐ and/or organ‐threatening disease.Study Design: Retrospective analysis of pathology specimens and EBV serology titers of pediatric organ transplant recipients at a tertiary care academic medical center.Methods: Immunohistochemical staining of tonsillectomy specimens and analysis of EBV serology titers were performed on 47 post‐transplantation children. Eligible patients included those under age 21 years referred for tonsillectomy who had undergone solid organ transplantation. Data reviewed included gender, age at transplantation, age at tonsillectomy, interval between organ transplantation and tonsillectomy, and type of organ transplanted. EBV was detected in tonsil specimens by in situ hybridization for EBV‐encoded small nuclear RNA (EBV‐EBER), an indicator of active EBV infection, and EBV‐encoded latent membrane protein (EBV‐LMP), an indicator of latent EBV infection. Immunohistochemical staining of B‐cell clonality was performed for kappa and lambda light chains. EBV serologies pre‐ and post‐transplantation were obtained from electronic medical record data.Results: Forty‐seven children having tonsillectomy following solid organ transplantation were included. Of the 47 patients, 25 (53.5%) were EBV seronegative both before transplantation and at the time of tonsillectomy, eight (17.0%) were EBV seronegative prior to transplantation but converted to EBV seropositivity in the early (≤6 months) post‐transplantation period, eight (17.0%) were seronegative prior to transplantation but converted to EBV seropositive in the late (≥6 months) post‐transplantation period, and six (12.8%) were EBV seropositive prior to transplantation and remained so at the time of tonsillectomy. Overall, 20 specimens (42.6%) were positive for EBV‐EBER, and three specimens (6.4%) were positive for EBV‐LMP. There was significant difference in the percentage of EBV‐EBER positive specimens among the four groups (P = .020). One out of eight (12.5%) of the early seroconversion group had specimens showing EBV‐EBER, wheras seven out of eight (87.5%) of the late seroconversion group had tonsil specimens showing EBV‐EBER (P = .005). There was no significant difference in presence of EBV‐LMP among the four groups (P = .667).Conclusions: Almost one half of post‐transplantation children undergoing tonsillectomy have evidence of active EBV tonsillar infection, which was more likely in children who seroconverted from EBV‐seronegative to EBV‐seropositive in the late post‐transplantation period than those who seroconverted in the early post‐transplantation period. Based on these novel findings, continued surveillance of EBV status and adenotonsillar hypertrophy in this population should include monitoring of pretransplantation EBV status and timing of seroconversion.


  • Open Access

    Immunohistochemical Analysis and Epstein-Barr Virus in the Tonsils of Transplant Recipients and Healthy Controls

    by Sarah E. Mowry, Ali M. Strocker, Jessica Chan, Christopher Takehana, Nader Kalantar, Sunita Bhuta, Nina L. Shapiro

    Posttransplantation lymphoproliferative disorder (PTLD), a spectrum of lymphoid dysplasias, affects 2% to 7% of patients after solid organ transplant.1 This disease is due to polyclonal immortalization of Epstein-Barr virus (EBV)-infected B lymphocytes in more than 80% of patients. Approximately 12% to 15% of PTLD cases are the result of T-cell proliferation.2 The mildest form of lymphoproliferative disorder is polyclonal lymphocyte proliferation, while the other end of the spectrum is aggressive large cell lymphoma. Early-stage lesions typically respond to decreased levels of immunosuppression. However, patients who develop PLTD within the transplanted organ or those who develop monoclonal lymphomas have substantially poorer outcomes. PTLD-related lymphoma still carries a 40% to 50% mortality rate.3


  • Cold Dissection Versus Coblation‐Assisted Adenotonsillectomy in Children

    by Nina L. Shapiro, Neil Bhattacharyya

    Objective: To compare intraoperative efficiency and postoperative recovery between cold dissection adenotonsillectomy (CDA) and coblation‐assisted adenotonsillectomy (CAA).Methods: A prospective, randomized, single‐blind trial of pediatric patients aged 2 to 16 years undergoing adenotonsillectomy was conducted. Patients were randomized to undergo either CDA or CAA. Measured intraoperative parameters included surgical duration and intraoperative blood loss. Measured postoperative parameters included a 14 day caregiver questionnaire that recorded a daily pain rating using the Wong‐Baker FACES pain scale, pain medication use, days to return to a normal diet, and days to return to a normal caregiver routine. Postoperative complications were also recorded. Intraoperative and postoperative measures were statistically compared between groups.Results: Forty‐six children with a mean age of 6.7 years (23 CDA and 23 CAA) were randomized and completed the study. Mean age and sex distributions were similar between groups (P > .05). Surgical times were significantly shorter for the CAA group versus the CDA group (11.2 min vs. 17.0 min, P < .001). Intraoperative blood loss was statistically lower for both the adenoidectomy and tonsillectomy portions of the procedure for the CAA group versus the CDA group (P < .001 and P < .001, respectively). There was no statistically significant difference in reported daily pain scores between groups (P = .296, analysis of variance). Both groups returned to normal diet (P = .982), and caregivers returned to their normal routine on similar postoperative days (P = .631).Conclusions: CAA offers better operative speed and intraoperative hemostasis as compared with CDA. However, CAA does not result in poorer postoperative pain scores or recoveries despite these intraoperative advantages.


  • Clinical Characteristics and Survival for Major Salivary Gland Malignancies in Children

    by Nina L. Shapiro, Neil Bhattacharyya

    OBJECTIVE: Determine presentation and survival rates for malignant pediatric salivary gland neoplasms.METHODS: All cases of malignant neoplasms involving the parotid or submandibular gland in patients ages birth to 18 years were extracted from the Surveillance, Epidemiology, and End Results database (1988–2001). Variables included age, gender, tumor histology, size, follow‐up time, and vital status. Kaplan‐Meier survival curves were constructed.RESULTS: 113 primary salivary gland malignancies (103 parotid, 10 submandibular) were identified. Mean age at presentation was 13.2 years. Female:male ratio of 5:4. Mean tumor size was 2.5 cm. Among parotid tumors, there were 44 (43%) mucoepidermoid carcinomas and 35 (34%) acinic cell carcinomas. At a mean follow‐up of 69.4 months, 6 (5.8%) patients with parotid malignancy were deceased; none of the submandibular malignancies were fatal. Mean Kaplan‐Meier survival for parotid gland lesions was 153 months, with rhabdomyosarcomas exhibiting significantly worse survivals as compared to other malignancies (P < 0.001, log‐rank test).CONCLUSIONS: Both epithelial and mesenchymal tumors present in the pediatric salivary gland. Survival for both parotid and submandibular gland malignancies is good in children.